Symbols

Symbols

PTLO

PTLO

Portillo's: UBS downgrades to Neutral, lowers PT to $6 from $7.5.

Portillo's: Stephens & Co. Maintains Equal-Weight, PT Down to $6 from $8

Tuesday Nov 04, 2025

Portillo's Q3 Earnings: Margins Slip to 3.4%, Growth Narratives Tested

Wednesday Oct 29, 2025

Fast-Casual IPOs in 2021: First Watch Leads the Pack, Portillo's and Sweetgreen Face Challenges in 2025.

Tuesday Oct 21, 2025

Vanguard Consumer Discretionary ETF (VCR) Holdings See Strong Insider Buying Activity

Monday Oct 13, 2025

Jefferies Downgrades Portillo's to Hold, Sets $6 Price Target

Portillo's Downgraded to Hold from Buy with New PT of $6 by Jefferies

Tuesday Oct 07, 2025

B of A Securities Downgrades PTLO to Neutral, Cuts Price Target by 50% to $7.00

Middle Coast Investing's Q3 2025 Investor Letter: Portillo's (PTLO) and Top 5 Holdings

Monday Oct 06, 2025

Portillo's Announces Q3 2025 Earnings Webcast on November 4th

Portillo's Stock Downgraded and Price Target Cut by B of A Securities.

BofA Securities Downgrades Portillo's to Neutral with PT of $7.

Wednesday Sep 24, 2025

Portillo's Announces CEO Departure, Names Interim Leader Amid Slow Growth and Investor Pressure

Portillo's Stock Jumps 3.2% After Leadership Shake-Up

Portillo's CEO Michael Osanloo Resigns Amid Company's Performance Issues

Tuesday Sep 23, 2025

Portillo's Inc. shares fall 3.16% intraday after CEO Michael Osanloo departs.

Portillo's CEO Michael Osanloo Abruptly Departs Amid Sluggish Sales and Revised Growth Strategy

Merit Medical: Barrington Research Raises PT to $103 from $103, Maintains Outperform

Stephens & Co. Raises Portillo's PT to $10 from $9.

Portillo's Names Michael Miles Jr. as Interim CEO Amid Leadership Transition